WO2009060952A1 - 新規製剤 - Google Patents

新規製剤 Download PDF

Info

Publication number
WO2009060952A1
WO2009060952A1 PCT/JP2008/070338 JP2008070338W WO2009060952A1 WO 2009060952 A1 WO2009060952 A1 WO 2009060952A1 JP 2008070338 W JP2008070338 W JP 2008070338W WO 2009060952 A1 WO2009060952 A1 WO 2009060952A1
Authority
WO
WIPO (PCT)
Prior art keywords
novel preparation
aminoalkoxybibenzyls
solvates
hydrates
esters
Prior art date
Application number
PCT/JP2008/070338
Other languages
English (en)
French (fr)
Inventor
Yasushi Imada
Yasunari Shinkai
Matsuo Igaki
Original Assignee
Mitsubishi Tanabe Pharma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corporation filed Critical Mitsubishi Tanabe Pharma Corporation
Priority to CN200880115418A priority Critical patent/CN101854929A/zh
Priority to JP2009540100A priority patent/JP5479909B2/ja
Priority to KR1020107012608A priority patent/KR101122447B1/ko
Publication of WO2009060952A1 publication Critical patent/WO2009060952A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Abstract

　アミノアルコキシビベンジル類、その薬学上許容し得る塩、そのエステル、並びにそれらの溶媒和物及びそれらの水和物からなる群から選ばれる物質を有効成分とする新規な製剤を提供する。 　本発明によれば、アミノアルコキシビベンジル類、その薬学上許容し得る塩、そのエステル、並びにそれらの溶媒和物及びそれらの水和物からなる群から選ばれる物質を有効成分とし、血中濃度が持続された新規な製剤を提供することができる。
PCT/JP2008/070338 2007-11-09 2008-11-07 新規製剤 WO2009060952A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN200880115418A CN101854929A (zh) 2007-11-09 2008-11-07 新型制剂
JP2009540100A JP5479909B2 (ja) 2007-11-09 2008-11-07 新規製剤
KR1020107012608A KR101122447B1 (ko) 2007-11-09 2008-11-07 신규 제제

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007291570 2007-11-09
JP2007-291570 2007-11-09

Publications (1)

Publication Number Publication Date
WO2009060952A1 true WO2009060952A1 (ja) 2009-05-14

Family

ID=40625838

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/070338 WO2009060952A1 (ja) 2007-11-09 2008-11-07 新規製剤

Country Status (4)

Country Link
JP (2) JP5479909B2 (ja)
KR (1) KR101122447B1 (ja)
CN (3) CN101854929A (ja)
WO (1) WO2009060952A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101933918A (zh) * 2010-09-08 2011-01-05 苏州世林医药技术发展有限公司 盐酸沙格雷酯缓释制剂及制备方法
JP2013159609A (ja) * 2012-02-03 2013-08-19 Lab Servier トリメタジジンの持続放出のための医薬組成物
US8920840B2 (en) 2010-04-30 2014-12-30 Takeda Pharmaceutical Company Limited Enteric tablet
EP3845219A4 (en) * 2018-08-28 2022-06-08 Towa Pharmaceutical Co., Ltd. ACTIVE PARTICLE

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552165B (zh) * 2012-01-05 2014-07-16 金陵药业股份有限公司 一种盐酸沙格雷酯缓释微丸及其制备方法
KR101184725B1 (ko) 2012-04-04 2012-09-20 주식회사 셀트리온제약 사포그릴레이트를 포함하는 간섬유화 또는 간경변의 치료 또는 예방용 약제학적 조성물
CN104739752A (zh) * 2014-12-08 2015-07-01 济南齐拓医药科技有限公司 一种新型的盐酸沙格雷酯缓释制剂
JP7315383B2 (ja) * 2019-06-27 2023-07-26 株式会社Ｓｃｒｅｅｎホールディングス インクジェット用水性組成物及び固体製剤
CN111944529B (zh) * 2020-08-25 2021-09-14 武汉药谷生物工程有限公司 碳酸氢钠注射液包装用碳酸氢钠缓释片

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001139462A (ja) * 1999-11-10 2001-05-22 Dai Ichi Seiyaku Co Ltd 新規製剤
JP2002212062A (ja) * 2001-01-24 2002-07-31 Teijin Ltd 遅延放出制御組成物
JP2003024452A (ja) * 2001-07-16 2003-01-28 Kawasumi Lab Inc ステント及びステントグラフト
JP2007039353A (ja) * 2005-08-02 2007-02-15 Shionogi & Co Ltd 徐放性顆粒剤
WO2007058190A1 (ja) * 2005-11-16 2007-05-24 Tokai University Educational System 薬剤放出制御組成物および薬剤放出性医療器具

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832847A (ja) * 1981-08-20 1983-02-25 Mitsubishi Chem Ind Ltd （３−アミノプロポキシ）ビベンジル類
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
US20040242687A1 (en) * 2001-09-26 2004-12-02 Yoshikazu Kobayashi Thrombus/thrombogenesis inhibitors
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001139462A (ja) * 1999-11-10 2001-05-22 Dai Ichi Seiyaku Co Ltd 新規製剤
JP2002212062A (ja) * 2001-01-24 2002-07-31 Teijin Ltd 遅延放出制御組成物
JP2003024452A (ja) * 2001-07-16 2003-01-28 Kawasumi Lab Inc ステント及びステントグラフト
JP2007039353A (ja) * 2005-08-02 2007-02-15 Shionogi & Co Ltd 徐放性顆粒剤
WO2007058190A1 (ja) * 2005-11-16 2007-05-24 Tokai University Educational System 薬剤放出制御組成物および薬剤放出性医療器具

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8920840B2 (en) 2010-04-30 2014-12-30 Takeda Pharmaceutical Company Limited Enteric tablet
CN101933918A (zh) * 2010-09-08 2011-01-05 苏州世林医药技术发展有限公司 盐酸沙格雷酯缓释制剂及制备方法
JP2013159609A (ja) * 2012-02-03 2013-08-19 Lab Servier トリメタジジンの持続放出のための医薬組成物
EP3845219A4 (en) * 2018-08-28 2022-06-08 Towa Pharmaceutical Co., Ltd. ACTIVE PARTICLE

Also Published As

Publication number Publication date
CN101854929A (zh) 2010-10-06
KR101122447B1 (ko) 2012-03-20
CN103393623A (zh) 2013-11-20
CN104739819A (zh) 2015-07-01
JP2014040475A (ja) 2014-03-06
JP5479909B2 (ja) 2014-04-23
KR20100096147A (ko) 2010-09-01
JPWO2009060952A1 (ja) 2011-03-24

Similar Documents

Publication Publication Date Title
WO2009060952A1 (ja) 新規製剤
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
EP3626253A3 (en) Stable formulations of linaclotide
WO2009017837A3 (en) Sublingual fentanyl spray
WO2007087431A3 (en) Sublingual fentanyl spray
WO2007146248A3 (en) Stable laquinimod preparations
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
WO2007135527A3 (en) Benzimidazolyl compounds
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
MX2007014892A (es) Formas polimorficas del ester etilico del acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}- 1-metil-h-bencimidazol-5-carbonil)-piridin-2-il--amino]propionico .
WO2010114405A3 (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
AU2012259422A8 (en) Solid forms of a pharmaceutically active substance
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2009051119A1 (ja) ピリミジルインドリン化合物
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
WO2011012816A3 (fr) Formulation pharmaceutique
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2009140341A3 (en) Atorvastatin compositions
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
WO2011019326A3 (en) Solubility and stability enchancing pharmaceutical formulation
WO2010049449A3 (en) Novel salts of sunitinib
WO2007110834A3 (en) Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2008004100A3 (en) Therapeutic compounds
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880115418.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08848089

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009540100

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20107012608

Country of ref document: KR

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 08848089

Country of ref document: EP

Kind code of ref document: A1